Decreased brain serotonin in RBFOX1 mutant zebrafish and partial reversion of behavioural alterations by the SSRI fluoxetine
Maja R. Adel, Ester Antón-Galindo, Edurne Gago-Garcia, Angela Arias-Dimas, Concepció Arenas, Rafael Artuch, Bru Cormand, Noèlia Fernàndez-Castillo · FENS Forum 2024
The splicing factor RBFOX1 exerts a pleiotropic effect on numerous psychiatric and neurodevelopmental disorders; however, the exact working mechanisms remain largely unknown. One potential mechanism that could partially explain the influence of RBFOX1 on some psychiatric traits is through the modulation of the serotonergic system, a common target for medical intervention in psychiatric disorders associated with RBFOX1.Here we studied a rbfox1 mutant zebrafish model, carrying a rbfox1sa15940 allele that expresses a shorter, aberrant rbfox1 mRNA. In the homozygous rbfox1sa15940 zebrafish we obse
ePoster · Neuroscience